Bitetti Teresa Marie — SEC insider filings
SEC reporting owner CIK 1977608. 8 insider filings on record with FilingPulse; latest filed 2026-11-04.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2023-10-16 to 2026-11-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 96,621 shares, $1,828,867 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 8.
- Largest priced transaction: sale of 46,609 shares @ $20.89 ($973,662) in TAKEDA PHARMACEUTICAL CO LTD, filed 2026-11-04.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| TAKEDA PHARMACEUTICAL CO LTD (TAK) | President, OBU | 4 | — | 2 legs · 96,621 sh · $1,828,867 | 2 |
| Aura Biosciences, Inc. (AURA) | Director | 2 | — | — | 4 |
| Fusion Pharmaceuticals Inc. (FUSN) | Director | 2 | — | — | 2 |
Insider filings — Bitetti Teresa Marie
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-04 | 4 | TAKEDA PHARMACEUTICAL CO LTD (TAK) | Sale (S): 46,609 @ $20.89 | EDGAR |
| 2026-08-12 | 4 | TAKEDA PHARMACEUTICAL CO LTD (TAK) | Sale (S): 50,012 @ $17.10 | EDGAR |
| 2026-07-06 | 4 | TAKEDA PHARMACEUTICAL CO LTD (TAK) | Grant/award (A): 43,886 @ $0 | EDGAR |
| 2026-06-15 | 4 | Aura Biosciences, Inc. (AURA) | Grant/award (A): 15,000 @ $0 · Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2026-04-28 | 4 | TAKEDA PHARMACEUTICAL CO LTD (TAK) | Grant/award (A): 64,988 @ $0 | EDGAR |
| 2025-04-02 | 4 | Aura Biosciences, Inc. (AURA) | Grant/award (A): 21,000 @ $0 · Grant/award (A): 29,000 (derivative) @ $0 | EDGAR |
| 2024-06-04 | 4 | Fusion Pharmaceuticals Inc. (FUSN) | Disposition to issuer (D): 34,000 (derivative) | EDGAR |
| 2023-10-16 | 4 | Fusion Pharmaceuticals Inc. (FUSN) | Grant/award (A): 34,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-04-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1977608 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs